Hosted on MSN6h
MediWound announces Phase III CIDS publication on NexoBridMediWound (MDWD) announced the publication of its Phase III Children Innovative Debridement Study in Burns, the peer-reviewed Journal of the ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...
Findings in Burns Journal confirm NexoBrid’s superiority over standard of care in pediatric patients with deep thermal burnsNexoBrid is approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback